Accepted_test

Approaches to the analysis of fungal communities using the example of the human mycobiome patient with COVID-19

by Danil V Krivonos | Dmitry E Fedorov | Andrey V Orlov | Ksenia M Klimina | Vladimir A Veselovsky | Svetlana N Kovalchuk | Alexander V Pavlenko | Elena N Ilina | Research Institute for Systems Biology and Medicine (RISBM) | Research Institute for Systems Biology and Medicine (RISBM) | I.M. Sechenov First Moscow State Medical University | Federal Research and Clinical Centre of Physical and Chemical Medicine, Federal Medical and Biological Agency of Russia | Federal Research and Clinical Centre of Physical and Chemical Medicine, Federal Medical and Biological Agency of Russia | Research Institute for Systems Biology and Medicine (RISBM) | Research Institute for Systems Biology and Medicine (RISBM) | Research Institute for Systems Biology and Medicine (RISBM)

Abstract ID: 199

Event: BGRS-abstracts

Sections: [Sym 8] Section “Microbial communities of natural and anthropogenic habitats”

The aim of the work was to assess changes in the human mycobiome against the background of COVID-19, as well as to identify factors associated with changes in the composition of the fungal community. In our study, we carried out a taxonomic annotation of the mycobiome of patients with COVID-19 at the time of hospitalization and compared it with the state of the fungal microflora formed during treatment for coronavirus infection. The work also demonstrates differences between groups of patients at the first and second time points, which allows us to obtain a basic understanding of the trend in the direction of changes in the mycobiome during COVID-19 therapy.